{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:04Z","timestamp":1792245724305,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/npp.2017.295","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T17:13:06Z","timestamp":1512493986000},"page":"1457-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex"],"prefix":"10.1038","volume":"43","author":[{"given":"Elyza","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer C","family":"Dhamne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan O","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Honer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe E","family":"Super","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen HT","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera E","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill L","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rotenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-2953","authenticated-orcid":false,"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"key":"BFnpp2017295_CR1","first-page":"698","volume":"47","author":"SM Ametamey","year":"2006","unstructured":"Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S et al (2006). Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med 47: 698\u2013705.","journal-title":"J Nucl Med"},{"key":"BFnpp2017295_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature10658","volume":"480","author":"BD Auerbach","year":"2011","unstructured":"Auerbach BD, Osterweil EK, Bear MF (2011). Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480: 63\u201368.","journal-title":"Nature"},{"key":"BFnpp2017295_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s13311-015-0359-5","volume":"12","author":"PE Davis","year":"2015","unstructured":"Davis PE, Peters JM, Krueger DA, Sahin M (2015). Tuberous sclerosis: a new frontier in targeted treatment of autism. Neurotherapeutics 12: 572\u2013583.","journal-title":"Neurotherapeutics"},{"key":"BFnpp2017295_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","volume":"52","author":"PJ de Vries","year":"2015","unstructured":"de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC et al (2015). Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol 52: 25\u201335.","journal-title":"Pediatr Neurol"},{"key":"BFnpp2017295_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0959-437X(99)80007-0","volume":"9","author":"PB Dennis","year":"1999","unstructured":"Dennis PB, Fumagalli S, Thomas G (1999). Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 9: 49\u201354.","journal-title":"Curr Opin Genet Dev"},{"key":"BFnpp2017295_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13229-017-0142-z","volume":"8","author":"SC Dhamne","year":"2017","unstructured":"Dhamne SC, Silverman JL, Super CE, Lammers SHT, Hameed MQ, Modi ME et al (2017). Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism. Mol Autism 8: 26.","journal-title":"Mol Autism"},{"key":"BFnpp2017295_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ et al (2008). Reversal of learning deficits in a Tsc2+\/- mouse model of tuberous sclerosis. Nat Med 14: 843\u2013848.","journal-title":"Nat Med"},{"key":"BFnpp2017295_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuropharm.2012.07.030","volume":"64","author":"G Gilmour","year":"2013","unstructured":"Gilmour G, Broad LM, Wafford KA, Britton T, Colvin EM, Fivush A et al (2013). In vitro characterisation of the novel positive allosteric modulators of the mGlu(5) receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat. Neuropharmacology 64: 224\u2013239.","journal-title":"Neuropharmacology"},{"key":"BFnpp2017295_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.bmc.2006.10.038","volume":"15","author":"S Hintermann","year":"2007","unstructured":"Hintermann S, Vranesic I, Allgeier H, Brulisauer A, Hoyer D, Lemaire M et al (2007). ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies. Bioorg Med Chem 15: 903\u2013914.","journal-title":"Bioorg Med Chem"},{"key":"BFnpp2017295_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer CA, Klann E (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33: 67\u201375.","journal-title":"Trends Neurosci"},{"key":"BFnpp2017295_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1037\/0735-7044.115.5.1129","volume":"115","author":"A Holmes","year":"2001","unstructured":"Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR et al (2001). Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci 115: 1129\u20131144.","journal-title":"Behav Neurosci"},{"key":"BFnpp2017295_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/jpet.104.079244","volume":"313","author":"GG Kinney","year":"2005","unstructured":"Kinney GG, O'Brien JA, Lemaire W, Burno M, Bickel DJ, Clements MK et al (2005). A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther 313: 199\u2013206.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2017295_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012). mTOR signaling in growth control and disease. Cell 149: 274\u2013293.","journal-title":"Cell"},{"key":"BFnpp2017295_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.111.185660","volume":"339","author":"L Lindemann","year":"2011","unstructured":"Lindemann L, Jaeschke G, Michalon A, Vieira E, Honer M, Spooren W et al (2011). CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J Pharmacol Exp Ther 339: 474\u2013486.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2017295_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton JO, Sahin M (2014). The neurology of mTOR. Neuron 84: 275\u2013291.","journal-title":"Neuron"},{"issue":"Suppl 3","key":"BFnpp2017295_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1528-1167.2010.02604.x","volume":"51","author":"P Mares","year":"2010","unstructured":"Mares P, Mikulecka A, Ticha K, Lojkova-Janeckova D, Kubova H (2010). Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats. Epilepsia 51 (Suppl 3): 24\u201326.","journal-title":"Epilepsia"},{"key":"BFnpp2017295_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.biopsych.2013.05.038","volume":"75","author":"A Michalon","year":"2014","unstructured":"Michalon A, Bruns A, Risterucci C, Honer M, Ballard TM, Ozmen L et al (2014). Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Biol Psychiatry 75: 189\u2013197.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2017295_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","volume":"74","author":"A Michalon","year":"2012","unstructured":"Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG et al (2012). Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 74: 49\u201356.","journal-title":"Neuron"},{"key":"BFnpp2017295_CR19","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1523\/JNEUROSCI.4796-14.2015","volume":"35","author":"D Nie","year":"2015","unstructured":"Nie D, Chen Z, Ebrahimi-Fakhari D, Di Nardo A, Julich K, Robson VK et al (2015). The stress-induced Atf3-gelsolin cascade underlies dendritic spine deficits in neuronal models of tuberous sclerosis complex. J Neurosci 35: 10762\u201310772.","journal-title":"J Neurosci"},{"key":"BFnpp2017295_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuropharm.2012.12.003","volume":"82","author":"S Parmentier-Batteur","year":"2014","unstructured":"Parmentier-Batteur S, Hutson PH, Menzel K, Uslaner JM, Mattson BA, O'Brien JA et al (2014). Mechanism based neurotoxicity of mGlu5 positive allosteric modulators\u2014development challenges for a promising novel antipsychotic target. Neuropharmacology 82: 161\u2013173.","journal-title":"Neuropharmacology"},{"key":"BFnpp2017295_CR21","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1093\/hmg\/ddp176","volume":"18","author":"K Pollizzi","year":"2009","unstructured":"Pollizzi K, Malinowska-Kolodziej I, Doughty C, Betz C, Ma J, Goto J et al (2009). A hypomorphic allele of Tsc2 highlights the role of TSC1\/TSC2 in signaling to AKT and models mild human TSC2 alleles. Hum Mol Genet 18: 2378\u20132387.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2017295_CR22","doi-asserted-by":"publisher","first-page":"e1001627","DOI":"10.1371\/journal.pbio.1001627","volume":"11","author":"WB Potter","year":"2013","unstructured":"Potter WB, Basu T, O'Riordan KJ, Kirchner A, Rutecki P, Burger C et al (2013). Reduced juvenile long-term depression in tuberous sclerosis complex is mitigated in adults by compensatory recruitment of mGluR5 and Erk signaling. PLoS Biol 11: e1001627.","journal-title":"PLoS Biol"},{"key":"BFnpp2017295_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nmeth.1314","volume":"6","author":"EK Schmidt","year":"2009","unstructured":"Schmidt EK, Clavarino G, Ceppi M, Pierre P (2009). SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods 6: 275\u2013277.","journal-title":"Nat Methods"},{"key":"BFnpp2017295_CR24","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/npp.2014.13","volume":"39","author":"RR Seese","year":"2014","unstructured":"Seese RR, Maske AR, Lynch G, Gall CM (2014). Long-term memory deficits are associated with elevated synaptic ERK1\/2 activation and reversed by mGluR5 antagonism in an animal model of autism. Neuropsychopharmacology 39: 1664\u20131673.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2017295_CR25","doi-asserted-by":"publisher","first-page":"131ra151","DOI":"10.1126\/scitranslmed.3003501","volume":"4","author":"JL Silverman","year":"2012","unstructured":"Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS et al (2012). Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 4: 131ra151.","journal-title":"Sci Transl Med"},{"key":"BFnpp2017295_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1358\/dnp.2004.17.4.829052","volume":"17","author":"W Spooren","year":"2004","unstructured":"Spooren W, Gasparini F (2004). mGlu5 receptor antagonists: a novel class of anxiolytics? Drug News Perspect 17: 251\u2013257.","journal-title":"Drug News Perspect"},{"key":"BFnpp2017295_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nn.3911","volume":"18","author":"D Tian","year":"2015","unstructured":"Tian D, Stoppel LJ, Heynen AJ, Lindemann L, Jaeschke G, Mills AA et al (2015). Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion. Nat Neurosci 18: 182\u2013184.","journal-title":"Nat Neurosci"},{"key":"BFnpp2017295_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00259-007-0638-4","volume":"35","author":"V Treyer","year":"2008","unstructured":"Treyer V, Streffer J, Ametamey SM, Bettio A, Blauenstein P, Schmidt M et al (2008). Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. Eur J Nucl Med Mol Imaging 35: 766\u2013770.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFnpp2017295_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"PT Tsai","year":"2012","unstructured":"Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM et al (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488: 647\u2013651.","journal-title":"Nature"},{"key":"BFnpp2017295_CR30","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1093\/hmg\/dds262","volume":"21","author":"E Yuan","year":"2012","unstructured":"Yuan E, Tsai PT, Greene-Colozzi E, Sahin M, Kwiatkowski DJ, Malinowska IA (2012). Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. Hum Mol Genet 21: 4286\u20134300.","journal-title":"Hum Mol Genet"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2017295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017295","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp2017295.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:59:31Z","timestamp":1684454371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2017295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["BFnpp2017295"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.295","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]},"assertion":[{"value":"2 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}